Abstract
Heart failure can present clinically as primarily diastolic or systolic dysfunction or both. There is an increasing awareness that heart failure can occur in the presence of a normal left ventricular ejection fraction. Heart failure with normal left ventricular ejection fraction is frequently referred to as diastolic heart failure because of the presence of diastolic left ventricular dysfunction evident from impaired left ventricular relaxation. This article focuses on the treatment of hypertension and the role the kidney plays in selecting appropriate agents.
MeSH terms
-
Angiotensin II Type 1 Receptor Blockers / therapeutic use
-
Angiotensin-Converting Enzyme Inhibitors / therapeutic use
-
Calcium Channel Blockers / therapeutic use
-
Disease Progression
-
Diuretics / therapeutic use
-
Heart Failure, Diastolic / drug therapy*
-
Heart Failure, Diastolic / physiopathology
-
Humans
-
Hypertension / drug therapy*
-
Hypertension / physiopathology
-
Kidney / physiopathology*
-
Kidney Diseases / etiology
-
Kidney Diseases / physiopathology*
-
Prevalence
-
Renin-Angiotensin System
-
Stroke Volume*
Substances
-
Angiotensin II Type 1 Receptor Blockers
-
Angiotensin-Converting Enzyme Inhibitors
-
Calcium Channel Blockers
-
Diuretics